Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MTNR1A | P48039 | 4/20 | 0.38 |
| ▸ | MTNR1B | P49286 | 4/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | NCF1 | P14598 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13034778 | 0.96 | MEN1 (0.42) | MEN1KMT2AMTNR1AMTNR1BMAPK1 | |
| SCHEMBL26376485 | 0.89 | CES2 (0.44) | MEN1KMT2AKDM4ETSHRCES2 | |
| SCHEMBL22856118 | 0.89 | MEN1 (0.47) | MEN1KMT2AMTNR1AMTNR1BMAPK1 | |
| SCHEMBL13226895 | 0.89 | MEN1 (0.47) | MEN1KMT2AMTNR1AMTNR1BMAPK1 | |
| SCHEMBL22525359 | 0.89 | MEN1 (0.47) | MEN1KMT2AMTNR1AMTNR1BMAPK1 | |
| SCHEMBL24509114 | 0.89 | MEN1 (0.47) | MEN1KMT2AMTNR1AMTNR1BMAPK1 | |
| SCHEMBL12733551 | 0.88 | ALDH1A1 (0.41) | MEN1KMT2ATSHRCES2SMN1; SMN2 | |
| SCHEMBL7006602 | 0.88 | MEN1 (0.41) | MEN1KMT2AKDM4ETSHRCES2 | |
| SCHEMBL13040233 | 0.88 | MEN1 (0.41) | MEN1KMT2AKDM4ETSHRCES2 | |
| SCHEMBL13870367 | 0.88 | MEN1 (0.41) | MEN1KMT2AMTNR1AMTNR1BMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8247534-B2 | Synthesis of radiofluorinated peptide using microwave activation technology | GE HEALTHCARE AS (NO) | 2012-08-21 | — | — | US | disclosed |
| US-8247534-B2 | Synthesis of radiofluorinated peptide using microwave activation technology | GE HEALTHCARE AS (NO) | 2012-08-21 | — | — | US | disclosed |
| US-8241606-B2 | Synthesis of a radiofluorinated peptide using photolabile protecting groups | GE HEALTHCARE AS (NO) | 2012-08-14 | — | — | US | disclosed |
| US-8241606-B2 | Synthesis of a radiofluorinated peptide using photolabile protecting groups | GE HEALTHCARE AS (NO) | 2012-08-14 | — | — | US | disclosed |
| US-20100022746-A1 | SYNTHESIS OF A RADIOFLUORINATED PEPTIDE USING PHOTOLABILE PROTECTING GROUPS | GE HEALTHCARE AS (NO) | 2010-01-28 | — | — | US | disclosed |
| US-20100022746-A1 | SYNTHESIS OF A RADIOFLUORINATED PEPTIDE USING PHOTOLABILE PROTECTING GROUPS | GE HEALTHCARE AS (NO) | 2010-01-28 | — | — | US | disclosed |
| US-20100016551-A1 | SYNTHESIS OF RADIOFLUORINATED PEPTIDE USING MICROWAVE ACTIVATION TECHNOLOGY | GE HEALTHCARE AS (NO) | 2010-01-21 | — | — | US | disclosed |
| US-20100016551-A1 | SYNTHESIS OF RADIOFLUORINATED PEPTIDE USING MICROWAVE ACTIVATION TECHNOLOGY | GE HEALTHCARE AS (NO) | 2010-01-21 | — | — | US | disclosed |
| WO-2008075966-A9 | SYNTHESIS OF A RADIOFLUORINATED PEPTIDE USING PHOTOLABILE PROTECTING GROUPS | GE HEALTHCARE AS (NO) | 2008-10-30 | — | — | WO | disclosed |
| WO-2008075966-A2 | SYNTHESIS OF A RADIOFLUORINATED PEPTIDE USING PHOTOLABILE PROTECTING GROUPS | GE HEALTHCARE AS (NO) | 2008-06-26 | — | — | WO | disclosed |
| WO-2008072976-A2 | SYNTHESIS OF A RADIOFLUORINATED PEPTIDE USING MICROWAVE ACTIVATION TECHNOLOGY | GE HEALTHCARE AS (NO) | 2008-06-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100022746-A1 | SYNTHESIS OF A RADIOFLUORINATED PEPTIDE USING PHOTOLABILE PROTECTING GROUPS | QRFPR, DNPEP, VIP | MEN1 192/4885KMT2A 2596/4885MTNR1A 946/4885 |
| US-20100016551-A1 | SYNTHESIS OF RADIOFLUORINATED PEPTIDE USING MICROWAVE ACTIVATION TECHNOLOGY | VIP, QRFPR, GRPR | MEN1 18/4885KMT2A 2669/4885MTNR1A 1966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.